| Lyka Labs Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
500259
ISIN Demat:
INE933A01014
Book Value(₹): 37.02 NSE Symbol:
LYKALABS
Div & Yield(%):
N.A
Market Cap(₹ Cr): 220.39 P/E(TTM): N.A
EPS(TTM): N.A
Face Value(₹): 10.00 |
| Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | Dec 21 (₹ Cr) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 134.70 | 106.40 | 80.59 | 164.35 | 62.26 |
| Other Income | 2.34 | 1.65 | 3.45 | 2.72 | 2.21 |
| Stock Adjustments | 1.37 | 0.79 | 1.21 | 0.40 | -2.04 |
| Total Income | 138.41 | 108.84 | 85.25 | 167.47 | 62.43 |
| EXPENDITURE : | |||||
| Raw Materials | 54.60 | 43.73 | 30.27 | 31.27 | 21.48 |
| Power and Fuel Cost | 3.90 | 3.92 | 3.57 | 3.88 | 2.91 |
| Other Manufacturing Expenses | 5.22 | 4.49 | 2.81 | 2.25 | 2.27 |
| Selling and Administration Expenses | 18.99 | 13.20 | 11.18 | 12.04 | 5.63 |
| Miscellaneous Expenses | 1.39 | 1.33 | 8.06 | 6.26 | 1.91 |
| Employee Benefit Expenses | 34.09 | 26.01 | 17.48 | 16.22 | 13.03 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 20.23 | 16.15 | 11.88 | 95.55 | 15.20 |
| Interest | 2.30 | 4.80 | 11.57 | 19.92 | 25.55 |
| Gross Profit | 17.93 | 11.35 | 0.31 | 75.63 | -10.35 |
| Depreciation | 6.45 | 12.29 | 13.52 | 15.39 | 8.05 |
| Profit Before Tax | 11.48 | -0.94 | -13.21 | 60.24 | -18.40 |
| Current Tax | 2.72 | 1.60 | 0.21 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.52 | -0.26 | -0.13 | 20.34 | -3.94 |
| Reported Net Profit | 8.23 | -2.27 | -13.29 | 39.90 | -14.46 |
| Extraordinary Items | 0.00 | 0.04 | -7.06 | -3.09 | -1.43 |
| Adjusted Net Profit | 8.23 | -2.31 | -6.23 | 42.99 | -13.03 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | -103.65 | -101.38 | -88.09 | -127.99 | -113.54 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | -95.42 | -103.65 | -101.38 | -88.09 | -127.99 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 2.31 | -0.69 | -4.33 | 13.91 | -5.04 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 37.81 | 27.28 | 19.22 | 15.49 | 1.54 |
| Book Value(Adj)-Unit Curr | 37.81 | 27.28 | 19.22 | 15.49 | 1.54 |
